Truvestments Capital LLC Catalyst Pharmaceuticals, Inc. Transaction History
Truvestments Capital LLC
- $363 Million
- Q3 2024
A detailed history of Truvestments Capital LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 248 shares of CPRX stock, worth $5,007. This represents 0.0% of its overall portfolio holdings.
Number of Shares
248Holding current value
$5,007% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
325Shares Held
94.1MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$377 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$162 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$126 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$115 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$60.9 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.08B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...